Praxis Precision Medicines, Inc. (PRAX) earnings
PRAX earnings moved a median of -0.76% by the close. Quarterly and annual PRAX reports and results, each read against the price at its own news timestamp. Back to the PRAX overview →
28 measured PRAX earnings events.
Where these PRAX earnings landedvs 27 measured PRAX earnings reactions
| Middle 50% of PRAX earnings reactions | -2.95% to +4.55% |
|---|---|
| Median reaction (to close) | -0.76% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 PRAX earnings events with a measured close landed between -2.95% and +4.55%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Praxis Precision Medicin For: Sep 30 | SEC filing · Form 10-Q | -0.34% | +2.19% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results | Press release | -2.18% | +16.34% | |
| Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation | Press release | +1.51% | +5.86% | |
| Form 10-Q Praxis Precision Medicin For: Jun 30 | SEC filing · Form 10-Q | +3.69% | +5.62% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results | Press release | +3.69% | +5.62% | |
| Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | Press release | -1.92% | -0.29% | |
| Form 10-Q Praxis Precision Medicin For: Mar 31 | SEC filing · Form 10-Q | -3.63% | -4.50% | |
| Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results | Press release | -3.63% | -4.50% | |
| Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference | Press release | -0.01% | -1.94% | |
| Form 10-K Praxis Precision Medicin For: Dec 31 | SEC filing · Form 10-K | -5.00% | +5.27% | |
| Form 10-Q Praxis Precision Medicin For: Sep 30 | SEC filing · Form 10-Q | +0.13% | -2.66% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results | Press release | +0.13% | -2.66% | |
| Form 10-Q Praxis Precision Medicin For: Jun 30 | SEC filing · Form 10-Q | -0.75% | -1.75% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results | Press release | -0.75% | -1.75% | |
| Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results | Press release | -1.13% | — | |
| Form 10-Q Praxis Precision Medicin For: Mar 31 | SEC filing · Form 10-Q | -0.08% | +3.82% | |
| Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results | Press release | -0.08% | +3.82% | |
| Form 10-K Praxis Precision Medicin For: Dec 31 | SEC filing · Form 10-K | -1.61% | -3.38% | |
| Form 10-Q Praxis Precision Medicin For: Sep 30 | SEC filing · Form 10-Q | -17.65% | -0.76% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results | Press release | -17.65% | -0.76% | |
| Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 | Press release | +0.27% | -3.16% | |
| Form 10-Q Praxis Precision Medicin For: Jun 30 | SEC filing · Form 10-Q | +2.03% | +5.37% | |
| Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Results | Press release | +2.03% | +5.37% | |
| Praxis Precision Medicines to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 | Press release | +3.06% | +3.39% | |
| Form 10-Q Praxis Precision Medicin For: Mar 31 | SEC filing · Form 10-Q | +1.89% | -4.08% | |
| Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results | Press release | +1.89% | -4.08% | |
| Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 | Press release | +0.14% | -2.73% | |
| Form 10-K Praxis Precision Medicin For: Dec 31 | SEC filing · Form 10-K | -0.62% | -4.14% |
Keep exploring
More PRAX: analyst actions → · SEC filings → · PRAX overview →